谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

GS-005 Mrecist Outcomes in EMERALD-1: a Phase 3, Randomized, Placebo-Controlled Study of Transarterial Chemoembolization Plus Durvalumab With/without Bevacizumab in Participants with Embolization-Eligible Hepatocellular Carcinoma

Bruno Sangro,Masatoshi Kudo,Joseph Erinjeri,Shukui Qin,Zhenggang Ren,Stephen Chan,Yasuaki Arai,Jeong Heo, Ahn Mai, Jose Escobar,Yamil Alonso Lopez Chuken,Jung-Hwan Yoon, Won Young Tak,Tanita Suttichaimongkol,Mohamed Bouattour, Shi-Ming Lin,Magdalena Żotkiewicz,Sajid Ali, Gordon Cohen, Riccardo Lencioni

Journal of Hepatology（2024）

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要